| Item Type | Name |
|
Academic Article
|
Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
|
|
Academic Article
|
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.
|
|
Academic Article
|
CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.
|
|
Academic Article
|
Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.
|
|
Academic Article
|
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
|
|
Concept
|
Cisplatin
|
|
Academic Article
|
Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
|
|
Academic Article
|
Antitumor activity against human tumor samples of cis-diamminedichloroplatinum(II) and analogues at equivalent in vitro myelotoxic concentrations.
|
|
Academic Article
|
The activity of paclitaxel in gastrointestinal tumors.
|
|
Academic Article
|
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
|
|
Academic Article
|
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
|
|
Academic Article
|
Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
|
|
Academic Article
|
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
|
|
Academic Article
|
Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation.
|
|
Academic Article
|
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
|
|
Academic Article
|
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.
|
|
Academic Article
|
Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.
|
|
Academic Article
|
Prolonged chemotherapy for localised squamous carcinoma of the oesophagus.
|
|
Academic Article
|
Activity of 2-fluoro-Ara AMP against gynecologic tumors in the soft agar assay.
|
|
Academic Article
|
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
|
|
Academic Article
|
Multiple squamous cell carcinoma treated with intra-arterial cisplatin in a patient with rheumatoid arthritis.
|
|
Academic Article
|
Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction.
|
|
Academic Article
|
Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
|
|
Academic Article
|
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
|
|
Academic Article
|
Standard chemotherapy for gastric carcinoma: is it a myth?
|
|
Academic Article
|
Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
|
|
Academic Article
|
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.
|
|
Academic Article
|
Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
|
|
Academic Article
|
Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel.
|
|
Academic Article
|
Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
|
|
Academic Article
|
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
|
|
Academic Article
|
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
|
|
Academic Article
|
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
|
|
Academic Article
|
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.
|
|
Academic Article
|
Is the addition of cisplatin to S-1 better than S-1 alone for patients with advanced gastroesophageal cancer?
|
|
Academic Article
|
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
|
|
Academic Article
|
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
|
|
Academic Article
|
Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma.
|
|
Academic Article
|
A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinum.
|
|
Academic Article
|
Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.
|
|
Academic Article
|
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Cis-diaminodichloroplatinum (II) chemotherapy for advanced adenocarcinoma of the upper gastrointestinal tract.
|
|
Academic Article
|
Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin.
|
|
Academic Article
|
Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity.
|
|
Academic Article
|
Treatment of patients with upper gastrointestinal carcinomas.
|
|
Academic Article
|
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
|
|
Academic Article
|
Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
|
|
Academic Article
|
Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma.
|
|
Academic Article
|
Preoperative therapy for patients with resectable squamous cell carcinoma of the esophagus: are we still confused?
|
|
Academic Article
|
Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
|
|
Academic Article
|
Docetaxel-based chemotherapy in the treatment of gastric cancer.
|
|
Academic Article
|
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
|
|
Academic Article
|
Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer.
|
|
Academic Article
|
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
|
|
Academic Article
|
Treatment issues in pediatric gastric adenocarcinoma.
|
|
Academic Article
|
Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
|
|
Academic Article
|
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
|
|
Academic Article
|
Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.
|
|
Academic Article
|
An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study.
|
|
Academic Article
|
Longterm survival of a Western patient with metastatic gastric cancer treated with S-1 plus cisplatin.
|
|
Academic Article
|
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
|
|
Academic Article
|
Current treatment for localized anal carcinoma.
|
|
Academic Article
|
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
|
|
Academic Article
|
Are capecitabine and oxaliplatin as effective as fluorouracil and cisplatin for gastroesophageal cancer?
|
|
Academic Article
|
Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen.
|
|
Academic Article
|
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer.
|
|
Academic Article
|
Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.
|
|
Academic Article
|
Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
|
|
Academic Article
|
Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study.
|
|
Academic Article
|
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.
|
|
Academic Article
|
Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal.
|
|
Academic Article
|
Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction.
|
|
Academic Article
|
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
|
|
Academic Article
|
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.
|
|
Academic Article
|
Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.
|
|
Academic Article
|
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).
|
|
Academic Article
|
Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
|
|
Academic Article
|
American Society of Clinical Oncology, 45th Annual Meeting - Comparison of cisplatin/S-1 tablets with cisplatin/5-FU infusions for advanced gastric cancer
|
|
Academic Article
|
Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies.
|
|
Academic Article
|
Final Results of NRG Oncology RTOG 0246: An?Organ-Preserving Selective Resection Strategy in?Esophageal Cancer Patients Treated with Definitive?Chemoradiation.
|
|
Academic Article
|
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.
|
|
Academic Article
|
Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer.
|
|
Academic Article
|
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.
|
|
Academic Article
|
Taxane- Versus Cisplatin-Based Chemotherapy With Radiation Therapy Is a Better Platform to Refine Esophageal Cancer Therapy.
|
|
Academic Article
|
Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin.
|
|
Academic Article
|
Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology.
|
|
Academic Article
|
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
|